Demcizumab

DB12734InvestigationalProtein Based Therapies

Demcizumab is under investigation for the treatment of Nonsquamous Nonsmall Cell Neoplasm of Lung.

Mechanism: Pharmacologically active on Delta-like protein 4
Curator reviewed

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

382Drug interactionsStructured to mechanism, not free text

6Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Demcizumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.